Sabine Brookman‐May
Ludwig-Maximilians-Universität München, Janssen (United States)
Papers
5
Total Citations
154
H-Index
4
About
Sabine Brookman‐May is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for patients with kidney and prostate cancers. Her major contributions center on refining partial nephrectomy techniques—particularly through the development and validation of the Surface-Intermediate-Base (SIB) margin score, a standardized system to report resection techniques and predict positive surgical margins. In a landmark prospective multicenter study (2019, 93 citations), she demonstrated how different resection techniques impact perioperative outcomes, acute kidney injury, and margin status after partial nephrectomy for localized renal masses. Her work on highly complex renal tumors (2021, 36 citations) further clarified how surgical approach and technique influence "Trifecta" failure—a composite of optimal oncologic, functional, and safety outcomes. Brookman‐May has also advanced prostate cancer care, leading a meta-analysis (2023, 12 citations) showing that peritoneal interposition flaps reduce complications after robot-assisted radical prostatectomy. As a key member of the SIB International Consortium, she has driven multi-institutional prospective projects that provide evidence-based guidance for nephron-sparing surgery. With over 150 citations across her most-cited papers, her research directly shapes surgical decision-making and improves patient recovery and cancer control.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5